Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Konica Minolta ( (JP:4902) ) just unveiled an announcement.
Konica Minolta has recorded significant financial impacts due to strategic divestments and operational challenges. During the quarter ending December 2024, it reported a profit from the sale of Ambry Genetics, marking its exit from the precision medicine business, while facing impairment losses in its Industry Business segment due to intensified competition and changes in customer investment behaviors.
More about Konica Minolta
Konica Minolta, Inc. operates in the technology industry, focusing on imaging, precision medicine, and industrial businesses. Its primary products include office equipment, medical systems, and industrial optical systems, with a significant market focus on innovation and enhancing operational efficiency.
YTD Price Performance: -6.37%
Average Trading Volume: 2,278
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $1.94B
See more data about 4902 stock on TipRanks’ Stock Analysis page.
